Lmr Partners LLP Arcturus Therapeutics Holdings Inc. Transaction History
Lmr Partners LLP
- $18.1 Billion
- Q3 2025
A detailed history of Lmr Partners LLP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 50,000 shares of ARCT stock, worth $363,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$363,500% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARCT
# of Institutions
174Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...